New daily pill could ease heavy periods from fibroids
NCT ID NCT06671548
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily pill called relugolix can safely reduce heavy menstrual bleeding in women with uterine fibroids. About 120 premenopausal women will receive either relugolix or a placebo for several weeks. The main goal is to see if the drug lowers blood loss to near-normal levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAVY MENSTRUAL BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can watching videos before surgery calm nerves?
- A drug that may curb bleeding during fibroid surgery faces its first big test
- Vitamin cocktail may shrink fibroids, reduce surgery need
- Stiffness check could boost fibroid treatment success
- 700 women followed for over a decade to see which fibroid treatments last longest
- New surgical trick may cut bleeding in hysterectomy